Mexico Demands Missing COVAX VaccinesBy Rodrigo Andrade | Thu, 09/01/2022 - 10:00
Mexico Health Review 2022 Echo gathers the main leaders in the industry for two days of conferences and networking. The government reported that the country is still missing COVID-19 vaccines previously purchased through the Global Access Fund for Vaccines Against COVID-19 (COVAX). President López Obrador denounced that legal action will be taken against the organization.
Meanwhile, the Ministry of Public Administration (SFP) announced through the Official Gazette the disqualification of five clinical laboratories from any government contracts. The World Health Organization (WHO) seeks hope as monkeypox cases peak in Europe.
Here is the Week in Health!
Mexico Health Summit 2022 Echo in Full Swing
From Aug. 31 to Sept. 2, the main leaders and representatives of the sector gathered for the new edition of Mexico Health Summit. On Wednesday, the event was celebrated with face-to-face conferences and a networking cocktail. On Thursday and Friday, discussions continued virtually with more presentations and active online matchmaking. Market access, patient-centric models and digitization were some of the main topics addressed. If you missed anything, get all the insights at mexicobusiness.news.
Mexico Missing COVID-19 Vaccines From COVAX
After the president's statement, Deputy Minister of Health Hugo López-Gatell announced that the country received a “formal offer” for over 10 million vaccine shots from COVAX, to be delivered at the end of September. According to the UN, Mexico has only received 24.6 million doses from the 51.5 ordered from the organization. Read the whole story here.
SFP Bans Five Companies From Public Tenders
Valtrum, Internacional Impromed, Centrum Promotora, Equipos Falcón and Selecciones Médicas are the companies founded guilty of monopolistic practices in the health sector, especially in the clinical laboratories studies and blood banks subsectors, reported the Ministry of Public Administration (SFP). These companies are disqualified from receiving government contracts for the next seven years. Check out the article here.
PAHO Reinforces Genomic Surveillance in Latin America
PAHO gave genomic surveillance training to over 120 health professionals, with the aim of strengthening the subject in the region. "Studying the evolution of viruses is key to detecting mutations or variants that can modify the transmission rate or severity of a pathogen and affect the efficacy of diagnostic tests, vaccines and treatment," said Jairo Méndez, Emerging Viral Disease Advisor, PAHO. Read about the event here.
Monkeypox Cases Decrease
WHO expresses hope as the monkeypox outbreak shows sustained week-on-week improvement in France, Germany, Portugal, Spain and the UK. Europe is the region most affected by this disease. The organization asks to increase efforts to stop the spread. “We believe we can eliminate sustained human-to-human transmission of monkeypox in the region,” said Hans Kluge, Regional Director EU, WHO. More information here.
Experts of the Week!
Isabela Rivas, Medical Value Lead Lung Cancer, Roche Mexico
Sandra Sánchez-Oldenhave, President & CEO, PharmAdvice
Tony Sarraf, Vice President and Market Head (North Latin America), Ecolab